| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/26/2001 | WO2001028993A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2000059910A3 Tricyclic pyrazolone derivatives |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones |
| 04/26/2001 | DE19860972A1 Verfahren zur Herstellung derivatisierter Polymere A process for preparing derivatized polymers |
| 04/26/2001 | CA2387886A1 Bicyclic vasopressin agonists |
| 04/26/2001 | CA2387840A1 Tyrosine kinase inhibitors |
| 04/25/2001 | EP1093456A2 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/24/2001 | US6222048 Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
| 04/24/2001 | US6222034 As serotinin receptor antagonists; for therapy of depression, central nervous system disorders |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027103A1 Fab i inhibitors |
| 04/19/2001 | WO2000077008A3 Heteroaryl substituted piperidines as gaba brain receptor lingands |
| 04/19/2001 | WO2000073311A3 Tricyclic benzoylcyclohexanedione derivatives |
| 04/19/2001 | WO2000072802A8 Water soluble multi-biotin-containing compounds |
| 04/19/2001 | WO2000059911A3 Tricyclic cyclohexanedione derivatives |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/18/2001 | EP1091953A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
| 04/17/2001 | US6218417 Ace-inhibitor nitric salts |
| 04/17/2001 | US6218405 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 04/17/2001 | US6218381 Fused imidazole derivatives as multidrug resistance modulators |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/12/2001 | WO2001025241A2 Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides |
| 04/11/2001 | EP1090010A1 Thienopyridine compounds, their production and use |
| 04/11/2001 | EP1090009A2 Cell adhesion-inhibiting antinflammatory compounds |
| 04/11/2001 | EP1089988A1 Fluorophenyl resin compounds |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1064360C Fused imidazo [1,2-alpha] pyridines |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/10/2001 | US6215005 (2-(2-thienyl)ethylamino)(2-halophenyl)acetonitrile; reacting alkali metal cyanide, o-halobenzaldehyde and 2-(2-thienyl)-ethylamine; cyanation, reduction, alkylation, amination |
| 04/10/2001 | US6214862 Analyzing proteasome sensitivity proteolysis |
| 04/10/2001 | US6214838 Which are stable to metabolism by the body and exhibits anti-inflammatory activity, bone resorption inhibitory activity and activity in inhibiting production of immunocytokines |
| 04/10/2001 | CA2165618C Tricyclic oxime ethers; process for preparing the same and pharmaceutical compositions containing them |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001012602A8 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 04/04/2001 | EP1088824A2 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 04/04/2001 | EP1088823A1 Fused pyrrolocarbazoles |
| 04/04/2001 | EP1088821A1 Pharmaceutically active sulfonamide derivatives |
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087977A1 Thienodipyridine derivatives, production and use thereof |
| 04/04/2001 | EP1087976A1 Polymorphic clopidogrel hydrogenesulphate form |
| 04/04/2001 | EP1087939A1 Process for preparation of pyrimidinone derivatives |
| 04/04/2001 | CN1064045C Thienopyrimidine derivatives, their production and use |
| 04/04/2001 | CN1064044C Heterocyclic compounds, their production and use |
| 04/03/2001 | US6211369 Spiro compounds and the use thereof |
| 04/03/2001 | US6211227 Tricyclic compounds |
| 04/03/2001 | US6211211 Anxiolytic, anticonvulsant and antiepileptic agent |
| 04/03/2001 | US6211195 Nervous system, psychological and glandular disorders |
| 04/03/2001 | US6211193 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; antitumor and anticarcinogenic agents |
| 04/03/2001 | US6211189 Nitric oxide synthase inhibitors; antiinflammatory agents, analgesics |
| 04/03/2001 | US6210941 Methods for the detection and isolation of proteins |
| 04/03/2001 | US6210903 Amino acid sequence which is optionally modified and biotinylated |
| 04/03/2001 | CA2066234C Activation compounds and methods for nucleic acid sterilization |
| 04/03/2001 | CA2023951C N-hydroxy-dibenz¢b,e!oxepin -alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use as medicaments |
| 03/30/2001 | CA2321379A1 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 03/29/2001 | WO2001021621A1 BENZO-FUSED DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 03/29/2001 | WO2001021620A2 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines |
| 03/29/2001 | WO2001021602A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 03/29/2001 | WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| 03/29/2001 | WO2000078747A8 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 03/29/2001 | CA2387520A1 Amine derivatives |
| 03/28/2001 | EP1086105A1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086099A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP0842178B1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/28/2001 | CN1289336A Chemokine receptor antagonists and methods of use therefor |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/27/2001 | US6207704 For treating abnormal angiogenesis in an animal; for treating an immune reaction which results in pathology in an animal; diagnosis |
| 03/27/2001 | US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia |
| 03/22/2001 | WO2001019833A1 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019822A1 Antiviral agents |
| 03/22/2001 | WO2001019369A1 Use of thienopyrimidines |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | DE19944604A1 Aminderivate Amine derivatives |
| 03/22/2001 | CA2387123A1 Use of thienopyrimidines |
| 03/22/2001 | CA2384898A1 Antiviral agents |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1084269A1 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 03/21/2001 | EP1084125A1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |